Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome

被引:16
|
作者
Maidana, P. [1 ]
Fritzler, A. [1 ]
Mocarbel, Y. [2 ]
Perez Lana, M. B. [3 ]
Gonzalez, D. [1 ]
Rosales, M. [1 ]
Gonzalez de Chazal, F. [3 ]
Sternberg, K. [3 ]
Lamas Majek, E. [3 ]
Mallea-Gil, S. [4 ]
Genovesi, E. [2 ]
Pelayo, M. [2 ]
Fabre, B. [1 ]
Mesch, V [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Inst Fisiopatol & Bioquim Clin INFIBIOC, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Endocrinol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Ginecol, Buenos Aires, DF, Argentina
[4] Hosp Mil Cent, Serv Endocrinol, Buenos Aires, DF, Argentina
关键词
C-REACTIVE PROTEIN; INSULIN-RESISTANCE; ANDROGEN EXCESS; CHRONIC STRESS; HAIR CORTISOL; D DEFICIENCY; HS-CRP; OBESITY; WOMEN; HYPERANDROGENISM;
D O I
10.1038/s41598-019-40653-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vitamin D deficiency has been related with metabolic alterations in polycystic ovary syndrome (PCOS). As well, hyperactivation of adrenal axis can be programmed early in life and could be related later with PCOS development. Our aim was to establish the relationship between vitamin D and adrenal parameters with metabolic alterations and inflammation markers in PCOS. In 73 patients and 33 controls, 25-hydroxyvitamin D (25-OH-D), total and bioavailable testosterone (TT and bioT), androstenedione (A4), SHBG, cortisol, insulin, and C-reactive protein (hs-CRP) were determined; HOMA and lipid accumulation product (LAP) index were calculated. All parameters were higher in patients than in controls, except for SHBG and 25-OH-D which were lower. Binary regression analysis showed that differences in TT, bioT, A4, insulin and HOMA were independent of body mass index and waist circumference but SHBG, hs-CRP, LAP and 25-OH-D were related to body weight and fat distribution. Binary logistic regression analysis showed that cortisol and 25-OH-D could be associated to PCOS development. Correlations found between LAP and insulin, HOMA and hs-CRP confirm it is a good indicator of metabolic complications. Vitamin D and cortisol association to PCOS development justifies future research to understand the role of vitamin D in PCOS and analyze patient's perinatal history and its possible relationship with hyperactivation of adrenal axis in adult life.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Association Between Vitamin D and Adrenal Parameters with Metabolic and Inflammatory Markers in Polycystic Ovary Syndrome
    P. Maidana
    A. Fritzler
    Y. Mocarbel
    M. B. Perez Lana
    D. González
    M. Rosales
    F. González de Chazal
    K. Sternberg
    E. Lamas Majek
    S. Mallea-Gil
    E. Genovesi
    M. Pelayo
    B. Fabre
    V. Mesch
    Scientific Reports, 9
  • [2] Association between Vitamin D and Metabolic Indexes in Patients with Polycystic Ovary Syndrome
    Shen Shanmei
    Liu Jiayi
    Li Yikun
    Qiao Chengcheng
    Yang Jiamiao
    Bi, Yan
    Zhu, Dalong
    DIABETES, 2018, 67
  • [3] Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome
    Boshku, Aleksandra Atanasova
    Panova, Daniela Ivanova
    Ivanovska, Beti Zafirova
    VOJNOSANITETSKI PREGLED, 2019, 76 (07) : 703 - 709
  • [4] Vitamin D, cortisol, leptin and metabolic markers in women with polycystic ovary syndrome
    Maidana, P.
    Fritzler, A.
    Fernandez, G.
    Gonzalez, D.
    Ibar, C.
    Stemberg, K.
    Lamas Majek, E.
    Fabre, B.
    Mesch, V.
    CLINICA CHIMICA ACTA, 2019, 493 : S320 - S320
  • [5] Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome
    Keshavarz, M. A.
    Moradi, S.
    Emami, Z.
    Rohani, F.
    NETHERLANDS JOURNAL OF MEDICINE, 2017, 75 (05): : 190 - 195
  • [6] Association Between Polycystic Ovary Syndrome and Metabolic Syndrome
    Martin Velez, Leandro
    Beatriz Motta, Alicia
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (35) : 3999 - 4012
  • [7] Is the polycystic ovary syndrome the causative of the increase in inflammatory markers and metabolic risk?
    Rey-Roldan, Estela
    Perez Lana, Maria Belen
    Galluzzo, Liliana
    Blanco, Georgina
    Onetto, Claudia
    Straminsky, Vanesa
    Patricio Nolting, Manuel
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 141 - 144
  • [8] The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes
    Y. Çakıroğlu
    F. Vural
    B. Vural
    Journal of Endocrinological Investigation, 2016, 39 : 899 - 907
  • [9] The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes
    Cakiroglu, Y.
    Vural, F.
    Vural, B.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (08): : 899 - 907
  • [10] Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
    Jena, Sweekruti
    Mishra, Ipsita
    Baliarsinha, Anoj Kumar
    Jena, Debarchan
    Debata, Madhumita
    JOURNAL OF HUMAN REPRODUCTIVE SCIENCES, 2023, 16 (02) : 132 - 139